Eledon Pharmaceuticals, Inc.(ELDN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ELDN Eledon Pharmaceuticals, Inc.

交易中 04-16 11:35:51 EDT

3.34

+0.04

+1.21%

最高3.42	最低3.28	成交量73.29万
今开3.40	昨收3.30	日振幅4.39%
总市值2.53亿	流通市值2.29亿	总股本7,585万
成交额244.35万	换手率1.07%	流通股本6,858万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ELDN","market":"US","secType":"STK","nameCN":"Eledon Pharmaceuticals, Inc.","latestPrice":3.34,"timestamp":1776353724227,"preClose":3.3,"halted":0,"volume":732878,"delay":0,"changeRate":0.012121212121212133,"floatShares":68583200,"shares":75851722,"eps":-0.556639,"marketStatus":"交易中","change":0.04,"latestTime":"04-16 11:35:51 EDT","open":3.4,"high":3.42,"low":3.275,"amount":2443461.1301628,"amplitude":0.043939,"askPrice":3.35,"askSize":436,"bidPrice":3.34,"bidSize":673,"shortable":3,"etf":0,"ttmEps":-0.556639,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1776369600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":3.3,"preHourTrading":{"tag":"盘前","latestPrice":3.5,"preClose":3.3,"latestTime":"09:29 EDT","volume":14701,"amount":50775.147346699996,"timestamp":1776346178509,"change":0.2,"changeRate":0.060606,"amplitude":0.034667},"postHourTrading":{"tag":"盘后","latestPrice":3.39,"preClose":3.3,"latestTime":"19:55 EDT","volume":32345,"amount":108482.7014,"timestamp":1776297302011,"change":0.09,"changeRate":0.027273,"amplitude":0.027273},"volumeRatio":1.715523,"impliedVol":1.7592,"impliedVolPercentile":0.652},"requestUrl":"/m/hq/s/ELDN","defaultTab":"news","newsList":[{"id":"1194646528","title":"Eledon公布Tegoprubart在芝加哥大学医学中心1型糖尿病患者胰岛移植试验的最新数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1194646528","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194646528?lang=zh_cn&edition=full","pubTime":"2026-03-16 19:02","pubTimestamp":1773658920,"startTime":"0","endTime":"0","summary":"Eledon Pharmaceuticals, Inc. 披露了由研究者发起的Tegoprubart用于1型糖尿病患者胰岛移植试验的最新数据，该试验在芝加哥大学医学中心进行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELDN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177535640","title":"Eledon Pharmaceuticals宣布Tegoprubart获孤儿药资格认定 用于预防肝移植排斥反应","url":"https://stock-news.laohu8.com/highlight/detail?id=1177535640","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177535640?lang=zh_cn&edition=full","pubTime":"2026-03-10 19:02","pubTimestamp":1773140536,"startTime":"0","endTime":"0","summary":"Eledon Pharmaceuticals, Inc.（ELDN）今日宣布，其研发药物Tegoprubart已获得孤儿药资格认定，适应症为预防肝移植中的同种异体移植物排斥反应。\n孤儿药资格认定将为Tegoprubart的后续开发提供政策支持，包括临床试验税收优惠、上市申请费用减免以及获批后的市场独占期等优势。该认定进一步凸显了Tegoprubart在解决肝移植领域未满足医疗需求方面的潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELDN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618267512","title":"Eledon Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.76%报2.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618267512","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618267512?lang=zh_cn&edition=full","pubTime":"2026-03-09 21:30","pubTimestamp":1773063036,"startTime":"0","endTime":"0","summary":"北京时间2026年03月09日21时30分，Eledon Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.76%。截至发稿，该股报2.94美元/股，成交量19.1976万股，换手率0.24%，振幅3.60%。Eledon Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Relmada Therapeutics, Inc.、Xenon制药、Uniqure N.V.涨幅较大，Relmada Therapeutics, Inc.、Moolec Science Sa、Quince Therapeutics, Inc.较为活跃，换手率分别为29.74%、18.74%、13.13%，振幅较大的相关个股有Aditxt, Inc.、Scinai Immunotherapeutics Ltd、Reviva Pharmaceuticals Holdings, Inc.，振幅分别为9.79%、8.10%、7.28%。Eledon Pharmaceuticals, Inc.公司简介：Eledon Pharmaceuticals Inc 是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309213036954616ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309213036954616ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ELDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605407043","title":"Eledon Pharmaceuticals, Inc.盘中异动 股价大跌5.34%报2.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605407043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605407043?lang=zh_cn&edition=full","pubTime":"2026-01-24 01:18","pubTimestamp":1769188718,"startTime":"0","endTime":"0","summary":"北京时间2026年01月24日01时18分，Eledon Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.34%。Eledon Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.90%。其相关个股中，Revelation Biosciences, Inc.、Coherus Oncology, Inc.、Collplant Biotechnologies Ltd.涨幅较大，Revelation Biosciences, Inc.、60 Degrees Pharmaceuticals, Inc.、Aditxt, Inc.较为活跃，换手率分别为1134.10%、142.01%、37.91%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、Revelation Biosciences Inc C/Wts 10/01/2027 、Revelation Biosciences, Inc.，振幅分别为60.41%、58.89%、50.33%。Eledon Pharmaceuticals, Inc.公司简介：Eledon Pharmaceuticals Inc 是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012401183897a32bd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012401183897a32bd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELDN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603653037","title":"Eledon Pharmaceuticals, Inc.盘中异动 早盘快速下挫6.40%报1.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603653037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603653037?lang=zh_cn&edition=full","pubTime":"2026-01-13 22:30","pubTimestamp":1768314632,"startTime":"0","endTime":"0","summary":"北京时间2026年01月13日22时30分，Eledon Pharmaceuticals, Inc.股票出现异动，股价大幅跳水6.40%。截至发稿，该股报1.79美元/股，成交量2.9025万股，换手率0.04%，振幅1.01%。Eledon Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Decoy Therapeutics Inc.、Briacell Therapeutics Corp.、Xtl生物制药涨幅较大，Scisparc Ltd.、Decoy Therapeutics Inc.、Briacell Therapeutics Corp.较为活跃，换手率分别为1053.25%、898.80%、240.30%，振幅较大的相关个股有Decoy Therapeutics Inc.、Briacell Therapeutics Corp.、Armata Pharmaceuticals, Inc.，振幅分别为11.04%、10.47%、8.53%。Eledon Pharmaceuticals, Inc.公司简介：Eledon Pharmaceuticals Inc 是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113223032a4bf493e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113223032a4bf493e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ELDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2600089091","title":"Eledon Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.30%报1.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2600089091","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600089091?lang=zh_cn&edition=full","pubTime":"2026-01-02 22:30","pubTimestamp":1767364229,"startTime":"0","endTime":"0","summary":"北京时间2026年01月02日22时30分，Eledon Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.30%。Eledon Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Genenta Science Spa、Sellas Life Sciences Group, Inc.涨幅较大，Sensei Biotherapeutics, Inc.、Can Fite Biopharma Ltd、Outlook Therapeutics, Inc.较为活跃，换手率分别为45.77%、35.36%、18.44%，振幅较大的相关个股有Geovax Labs, Inc.、Moolec Science Sa、Mereo Biopharma Group Plc，振幅分别为6.84%、5.97%、5.59%。Eledon Pharmaceuticals, Inc.公司简介：Eledon Pharmaceuticals Inc 是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102223029a6ebe844&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102223029a6ebe844&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ELDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588886082","title":"Eledon Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.21%报1.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588886082","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588886082?lang=zh_cn&edition=full","pubTime":"2025-12-02 04:42","pubTimestamp":1764621740,"startTime":"0","endTime":"0","summary":"北京时间2025年12月02日04时42分，Eledon Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.21%。Eledon Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.57%。其相关个股中，Q32 Bio Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Kala Bio, Inc.涨幅较大，Kala Bio, Inc.、Q32 Bio Inc.、Aditxt, Inc.较为活跃，换手率分别为2025.46%、1341.02%、164.98%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Q32 Bio Inc.、Kala Bio, Inc.，振幅分别为121.69%、116.43%、76.60%。Eledon Pharmaceuticals, Inc.公司简介：Eledon Pharmaceuticals Inc 是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202044220a71d8a15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202044220a71d8a15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ELDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586440749","title":"Eledon Pharmaceuticals, Inc.盘中异动 早盘股价大涨6.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586440749","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586440749?lang=zh_cn&edition=full","pubTime":"2025-11-25 00:28","pubTimestamp":1764001725,"startTime":"0","endTime":"0","summary":"北京时间2025年11月25日00时28分，Eledon Pharmaceuticals, Inc.股票出现波动，股价快速上涨6.60%。Eledon Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Enlivex Therapeutics Ltd.、Osr Holdings Inc C/Wts 09/02/2028 涨幅较大，Enlivex Therapeutics Ltd.、Pasithea Therapeutics Corp.、Osr Holdings, Inc.较为活跃，换手率分别为743.62%、503.57%、93.12%，振幅较大的相关个股有Enlivex Therapeutics Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 ，振幅分别为56.87%、45.45%、42.12%。Eledon Pharmaceuticals, Inc.公司简介：Eledon Pharmaceuticals Inc 是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125002845a70eb3f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125002845a70eb3f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELDN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2585817284","title":"Eledon Pharmaceuticals, Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585817284","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585817284?lang=zh_cn&edition=full","pubTime":"2025-11-22 01:25","pubTimestamp":1763745927,"startTime":"0","endTime":"0","summary":"北京时间2025年11月22日01时25分，Eledon Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.04%。Eledon Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.08%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Osr Holdings, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Osr Holdings, Inc.、Pasithea Therapeutics Corp.、Psyence Biomedical Ltd.较为活跃，换手率分别为444.54%、22.53%、21.24%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Osr Holdings, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为63.22%、49.71%、47.00%。Eledon Pharmaceuticals, Inc.公司简介：Eledon Pharmaceuticals Inc 是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112201252795131463&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112201252795131463&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ELDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145377868","title":"Eledon Pharmaceuticals 股价在糖尿病患者药物测试初步更新后上涨约 10% 至 1.69 美元，活跃交易量增加","url":"https://stock-news.laohu8.com/highlight/detail?id=1145377868","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145377868?lang=zh_cn&edition=full","pubTime":"2025-11-19 06:19","pubTimestamp":1763504348,"startTime":"0","endTime":"0","summary":"Eledon Pharmaceuticals 股价在糖尿病患者药物测试的初步更新发布后，交易量活跃，上涨约 10% 至 1.69 美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELDN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156799599","title":"Eledon公布首六名接受以Tegoprubart为核心免疫抑制剂的1型糖尿病患者初步数据，研究在芝加哥大学医学中心进行","url":"https://stock-news.laohu8.com/highlight/detail?id=1156799599","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156799599?lang=zh_cn&edition=full","pubTime":"2025-11-19 05:06","pubTimestamp":1763499970,"startTime":"0","endTime":"0","summary":"Eledon公布首六名接受以Tegoprubart为核心免疫抑制剂、在芝加哥大学医学中心进行的研究中进行胰岛移植的1型糖尿病患者的初步数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELDN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165846126","title":"Eledon Pharmaceuticals拟议承销普通股及预售认购权证的公开发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1165846126","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165846126?lang=zh_cn&edition=full","pubTime":"2025-11-12 06:28","pubTimestamp":1762900091,"startTime":"0","endTime":"0","summary":"Eledon Pharmaceuticals拟议承销普通股及预售认购权证的公开发行","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELDN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2577340945","title":"Eledon Pharmaceuticals, Inc.盘中异动 急速下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577340945","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577340945?lang=zh_cn&edition=full","pubTime":"2025-10-22 22:22","pubTimestamp":1761142943,"startTime":"0","endTime":"0","summary":"北京时间2025年10月22日22时22分，Eledon Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.01%。Eledon Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 14/02/2029 、Adaptimmune Therapeutics Plc、Engene Holdings Inc C/Wts 31/10/2028  Cl A涨幅较大，Rani Therapeutics Holdings, Inc.、Adaptimmune Therapeutics Plc、Minerva Neurosciences, Inc较为活跃，换手率分别为69.85%、55.92%、29.01%，振幅较大的相关个股有Adaptimmune Therapeutics Plc、Apollomics Inc C/Wts 01/04/2028 、Celularity Inc C/Wts 16/07/2026 ，振幅分别为54.32%、29.17%、28.61%。Eledon Pharmaceuticals, Inc.公司简介：Eledon Pharmaceuticals Inc 是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102222222394d7efb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102222222394d7efb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELDN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518783619","title":"Eledon Pharmaceuticals, Inc.盘中异动 临近收盘大幅跳水5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518783619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518783619?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:59","pubTimestamp":1741636796,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时59分，Eledon Pharmaceuticals, Inc.股票出现波动，股价大幅跳水5.41%。截至发稿，该股报3.59美元/股，成交量34.9116万股，换手率0.58%，振幅5.54%。Eledon Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。其相关个股中，Checkpoint Therapeutics, Inc.、Protagonist Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6578.13%、3906.94%、1043.46%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为90.44%、88.14%、72.15%。Eledon Pharmaceuticals, Inc.公司简介：Eledon Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311035957a26abaef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311035957a26abaef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELDN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506301497","title":"Eledon Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506301497","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506301497?lang=zh_cn&edition=full","pubTime":"2025-01-27 23:58","pubTimestamp":1737993494,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日23时58分，Eledon Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.30%。截至发稿，该股报4.67美元/股，成交量9.3519万股，换手率0.16%，振幅5.80%。Eledon Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。其相关个股中，Akero Therapeutics, Inc.、Onconetix, Inc.、89Bio, Inc.涨幅较大，Onconetix, Inc.、Evaxion Biotech As、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为1936.82%、216.17%、137.28%，振幅较大的相关个股有Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Immatics N V C/Wts 01/07/2025 ，振幅分别为85.35%、65.16%、61.25%。Eledon Pharmaceuticals, Inc.公司简介：Eledon Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127235814a2317c2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127235814a2317c2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELDN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506898635","title":"Eledon Pharmaceuticals, Inc.盘中异动 临近午盘股价大涨5.25%报4.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506898635","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506898635?lang=zh_cn&edition=full","pubTime":"2025-01-25 00:39","pubTimestamp":1737736760,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日00时39分，Eledon Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.25%。截至发稿，该股报4.47美元/股，成交量11.0519万股，换手率0.19%，振幅6.59%。Eledon Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Evaxion Biotech As、Pmgc Holdings Inc.、Immatics N V C/Wts 01/07/2025 涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为3919.54%、2137.18%、1590.85%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Evaxion Biotech As、Windtree Therapeutics, Inc.，振幅分别为134.08%、112.09%、66.25%。Eledon Pharmaceuticals, Inc.公司简介：Eledon Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125003920a22e75f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125003920a22e75f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELDN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503622470","title":"Eledon Pharmaceuticals, Inc.盘中异动 股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503622470","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503622470?lang=zh_cn&edition=full","pubTime":"2025-01-16 01:04","pubTimestamp":1736960657,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日01时04分，Eledon Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.26%。Eledon Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Aditxt, Inc.、Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.较为活跃，换手率分别为746.80%、219.64%、178.38%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Os Therapies Incorporated、Aditxt, Inc.，振幅分别为68.03%、64.66%、63.36%。Eledon Pharmaceuticals, Inc.公司简介：Eledon Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011601041798675f37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011601041798675f37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELDN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503868676","title":"Eledon Pharmaceuticals, Inc.盘中异动 下午盘急速跳水5.01%报3.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503868676","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503868676?lang=zh_cn&edition=full","pubTime":"2025-01-15 03:55","pubTimestamp":1736884541,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日03时55分，Eledon Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.01%。Eledon Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.86%。其相关个股中，Eterna Therapeutics Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 、Matinas Biopharma Holdings, Inc.涨幅较大，Eterna Therapeutics Inc.、Phio Pharmaceuticals Corp.、Soligenix, Inc.较为活跃，换手率分别为1079.75%、598.94%、421.28%，振幅较大的相关个股有Eterna Therapeutics Inc.、Matinas Biopharma Holdings, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为170.74%、69.81%、69.33%。Eledon Pharmaceuticals, Inc.公司简介：Eledon Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501150355419866375a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501150355419866375a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELDN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503873605","title":"Eledon Pharmaceuticals, Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503873605","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503873605?lang=zh_cn&edition=full","pubTime":"2025-01-14 00:14","pubTimestamp":1736784852,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日00时14分，Eledon Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.07%。截至发稿，该股报3.84美元/股，成交量9.7967万股，换手率0.16%，振幅5.32%。Eledon Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.00%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为11435.43%、6209.86%、425.33%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.，振幅分别为336.09%、216.61%、124.54%。Eledon Pharmaceuticals, Inc.公司简介：Eledon Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114001412aba949fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114001412aba949fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELDN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502867685","title":"Eledon Pharmaceuticals, Inc.盘中异动 股价大跌5.00%报4.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502867685","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502867685?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:47","pubTimestamp":1736520470,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时47分，Eledon Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.00%。截至发稿，该股报4.09美元/股，成交量1.9382万股，换手率0.03%，振幅2.91%。Eledon Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.85%。其相关个股中，Conduit Pharmaceuticals Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 、Precision Biosciences, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Precision Biosciences, Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为1058.81%、175.54%、159.06%，振幅较大的相关个股有Zyversa Therapeutics, Inc.、Precision Biosciences, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为37.29%、36.44%、30.12%。Eledon Pharmaceuticals, Inc.公司简介：Eledon Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110224751aba606ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110224751aba606ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ELDN"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.eledon.com","stockEarnings":[{"period":"1week","weight":0.0543},{"period":"1month","weight":0.2044},{"period":"3month","weight":0.5942},{"period":"6month","weight":-0.0407},{"period":"1year","weight":0.0963},{"period":"ytd","weight":1.1854}],"compareEarnings":[{"period":"1week","weight":0.0354},{"period":"1month","weight":0.0462},{"period":"3month","weight":0.0111},{"period":"6month","weight":0.0535},{"period":"1year","weight":0.3019},{"period":"ytd","weight":0.0264}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Eledon Pharmaceuticals, Inc.于2004年3月26日根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，专注于为需要基于器官或细胞的移植、患有自身免疫性疾病或患有肌萎缩侧索硬化症的人开发改变生命的靶向药物。该公司在研的先导化合物是tegoprubart，这是一种IgG1、抗CD40L抗体，对CD40 Ligand具有高亲和力，这是一个经过充分验证的生物靶点，他们认为该靶点具有广泛的治疗潜力。","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":0.166113},{"month":2,"riseRate":0.583333,"avgChangeRate":-0.000872},{"month":3,"riseRate":0.416667,"avgChangeRate":-0.044379},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.000143},{"month":5,"riseRate":0.545455,"avgChangeRate":0.811807},{"month":6,"riseRate":0.181818,"avgChangeRate":-0.182936},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.081289},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.035259},{"month":9,"riseRate":0.272727,"avgChangeRate":0.085532},{"month":10,"riseRate":0.5,"avgChangeRate":2.263696},{"month":11,"riseRate":0.5,"avgChangeRate":-0.069266},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.094259}],"exchange":"NASDAQ","name":"Eledon Pharmaceuticals, Inc.","nameEN":"Eledon Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Eledon Pharmaceuticals, Inc.(ELDN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Eledon Pharmaceuticals, Inc.(ELDN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Eledon Pharmaceuticals, Inc.,ELDN,Eledon Pharmaceuticals, Inc.股票,Eledon Pharmaceuticals, Inc.股票老虎,Eledon Pharmaceuticals, Inc.股票老虎国际,Eledon Pharmaceuticals, Inc.行情,Eledon Pharmaceuticals, Inc.股票行情,Eledon Pharmaceuticals, Inc.股价,Eledon Pharmaceuticals, Inc.股市,Eledon Pharmaceuticals, Inc.股票价格,Eledon Pharmaceuticals, Inc.股票交易,Eledon Pharmaceuticals, Inc.股票购买,Eledon Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Eledon Pharmaceuticals, Inc.(ELDN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Eledon Pharmaceuticals, Inc.(ELDN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}